CLOs on the Move

FSD Pharma

www.fsdpharma.com

 
FSD Pharma is transforming a large facility in Cobourg, Ontario Canada, into the largest hydroponic indoor cannabis production and processing facility in the world, with multiple business units co-supporting each other, operating under a single roof to exploit economies of scale and operational efficiencies. We are growing the future through innovation!
  • Number of Employees: 25-100
  • Annual Revenue: $50-100 Million
  • www.fsdpharma.com
  • 100 King Street West Suite 3400
    Toronto, ON CAN M5X 1A4
  • Phone: 647.864.7969

Executives

Name Title Contact Details

Similar Companies

HEXO Corporation

HEXO is an award-winning licensed producer of innovative products for the global cannabis market. HEXO serves the Canadian recreational market with a brand portfolio including HEXO, UP Cannabis, Original Stash, Bake Sale, Namaste, and REUP brands, and the medical market in Canada, Israel and Malta. The Company also serves the Colorado market through its Powered by HEXO® strategy and Truss CBD USA, a joint venture with Molson Coors. In the event that the previously announced transactions to acquire 48North and Redecan close, HEXO expects to be the number one cannabis products company in Canada by recreational market share.

Merck-Medco

Merck-Medco is a Franklin Lakes, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Forefront Dermatology

Forefront Dermatology is a leading dermatology group practice with numerous convenient locations throughout the United States. Find a dermatologist near me today.

Pharmaceutical Buyers

Pharmaceutical Buyers is a Cedarhurst, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Delcath

Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The company`s proprietary percutaneous hepatic perfusion (PHP) system is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. In the United States, the PHP system is being developed under the tradename HEPZATO KIT (melphalan hydrochloride for injection/hepatic delivery system), or HEPZATO, and is considered a combination drug and device product regulated by the United States Food and Drug Administration (FDA).